The U.K. Prime Minister, Theresa May has made her first appearance in a series on industrial strategy, whereby she has pledged millions of pounds of government funding to develop artificial intelligence to transform outcomes through early diagnosis of cancer and chronic disease.
Data is at the heart of applicable genomics. As the volume and depth of genomic data grows, bioinformaticians are translating the data into interpretable patterns leading to new biological insight.
Researchers at Oregon State University have developed a great new RNA annotation tool.
A new way to simplify complex biomolecular data about tumours could in principle make it easier to prescribe the appropriate treatment for a specific patient.
Illumina has revealed that it has acquired Edico Genome, with the intention of building on the solid foundation of DRAGEN, to deliver a more streamlines sample for customers.
A bit of advice for any criminals inspired to try and edit their own genes – it’s unlikely to work, and it may present health risks.
There are fears that CRISPR could be used by criminals to clear their names from forensic databases or evade detection, as access to the technique becomes more widely available.
Much of medicine is about information — the data that helps doctors make the right choices about our treatment. So how will the revolution in big data impact complex healthcare systems like the NHS?
Cryptographic system could enable ‘crowdsourced’ genomics, with volunteers contributing information to privacy-protected databases.
SOPHiA GENETICS, has announced that its technology for clinical genomics has reached a key milestone in helping better diagnose 200’000 patients. Already deployed in over 430 hospitals across 60 countries SOPHiA analyses today 1 patient every 5 minutes.
Technologies for amplifying, sequencing and matching DNA have created new opportunities in genomic science. But there are ethical and social implications.